Cell-based assays are useful tools for the diagnosis of potential autoimmune disease and are successfully used for targets such as GluN1 (NR1), dopamine D2 receptor (DR2), and myelin-oligodendrocyte glycoprotein. The gene discussed is GRIN1; the disease is autoimmune disease.